Drug profile

The FDA adverse-event record for Moraxella Bovis Bacterin (Solidtech)

13 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Moraxella Bovis Bacterin (Solidtech). See the species affected, top reactions, and outcomes below.

13
adverse-event reports
23.1%
death-coded share
Cattle
most-reported species
7
Lack of efficacy (bacteria) - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
3
Deaths Reported
23.1%
Death Rate

Active Ingredients

Moraxella Bovis Bacterin (Solidtech)

Administration Routes

SubcutaneousUnknown

Species Affected

Cattle 13

Most Affected Breeds

Cattle (other) 6
Aberdeen Angus 2
Mixed (Cattle) 2
Hereford cattle 1
Holstein-Friesian also known as Holstein 1
Red Angus 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 7
Lack of efficacy - NOS 4
Death 2
Keratoconjunctivitis 2
Cloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus - see 'Neurological') 2
Impaired vision 2
CULTURE/TITER DATA ABNORMAL 1
Abnormal necropsy finding 1
Pulmonary disorder NOS 1
Incorrect route of drug administration 1
Abortion 1
Stillbirth 1

Outcome Breakdown

Outcome Unknown
11 (64.7%)
Died
3 (17.6%)
Recovered/Normal
2 (11.8%)
Ongoing
1 (5.9%)

Moraxella Bovis Bacterin (Solidtech) Adverse Event Insights

13 reports name Moraxella Bovis Bacterin (Solidtech); 3 recorded a death outcome (23.1% of reported events, not a population-level mortality rate). Active ingredient: Moraxella Bovis Bacterin (Solidtech). Administration routes: Subcutaneous, Unknown.

By species: Cattle (13 reports). By breed: Cattle (other) (6), Aberdeen Angus (2), Mixed (Cattle) (2).

Leading clinical signs: Lack of efficacy (bacteria) - NOS (7), Lack of efficacy - NOS (4), Death (2), Keratoconjunctivitis (2). Outcome, 17 coded reports: Outcome Unknown leads at 64.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.